Correlation Between Incannex Healthcare and OWC Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Incannex Healthcare and OWC Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Incannex Healthcare and OWC Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Incannex Healthcare Ltd and OWC Pharmaceutical Research, you can compare the effects of market volatilities on Incannex Healthcare and OWC Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Incannex Healthcare with a short position of OWC Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Incannex Healthcare and OWC Pharmaceutical.

Diversification Opportunities for Incannex Healthcare and OWC Pharmaceutical

0.13
  Correlation Coefficient

Average diversification

The 3 months correlation between Incannex and OWC is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Incannex Healthcare Ltd and OWC Pharmaceutical Research in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OWC Pharmaceutical and Incannex Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Incannex Healthcare Ltd are associated (or correlated) with OWC Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OWC Pharmaceutical has no effect on the direction of Incannex Healthcare i.e., Incannex Healthcare and OWC Pharmaceutical go up and down completely randomly.

Pair Corralation between Incannex Healthcare and OWC Pharmaceutical

Given the investment horizon of 90 days Incannex Healthcare Ltd is expected to under-perform the OWC Pharmaceutical. But the stock apears to be less risky and, when comparing its historical volatility, Incannex Healthcare Ltd is 45.26 times less risky than OWC Pharmaceutical. The stock trades about -0.02 of its potential returns per unit of risk. The OWC Pharmaceutical Research is currently generating about 0.4 of returns per unit of risk over similar time horizon. If you would invest  0.00  in OWC Pharmaceutical Research on August 26, 2024 and sell it today you would earn a total of  0.01  from holding OWC Pharmaceutical Research or generate 9.223372036854776E16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Incannex Healthcare Ltd  vs.  OWC Pharmaceutical Research

 Performance 
       Timeline  
Incannex Healthcare 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Incannex Healthcare Ltd are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite quite fragile technical indicators, Incannex Healthcare disclosed solid returns over the last few months and may actually be approaching a breakup point.
OWC Pharmaceutical 

Risk-Adjusted Performance

25 of 100

 
Weak
 
Strong
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in OWC Pharmaceutical Research are ranked lower than 25 (%) of all global equities and portfolios over the last 90 days. Even with relatively uncertain fundamental indicators, OWC Pharmaceutical reported solid returns over the last few months and may actually be approaching a breakup point.

Incannex Healthcare and OWC Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Incannex Healthcare and OWC Pharmaceutical

The main advantage of trading using opposite Incannex Healthcare and OWC Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Incannex Healthcare position performs unexpectedly, OWC Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OWC Pharmaceutical will offset losses from the drop in OWC Pharmaceutical's long position.
The idea behind Incannex Healthcare Ltd and OWC Pharmaceutical Research pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets